Casinvent

Developer of therapeutics for leukemias, lymphomas, and solid tumors

placeBrno, South Moravian Region, Czech Republic calendar_todayFounded 2020 groups6 employees language casinvent.com

Social engagement

Social engagement: 717 social following, 8 posts in the last 12 months — top 10% of its industry.

Investor mix

5 investors on record.

Investor typeCountShare
Other / undisclosed5100%

Recent activity

30 Apr 2026
Milestone
regulatory
28 Nov 2025
Event
BioFIT Event 2025
24 Nov 2025
Product launch
CK1 inhibitor program
Coming soon